Interferon-gamma release assay for diagnosing Mycobacterium tuberculosis infections in patients with systemic lupus erythematosus

Lupus

Volumn 20, Issue 8, 2011, Pages 792-800

  Takeda, N ^a   Nojima, T ^a   Terao, C ^a   Yukawa, N ^a   Kawabata, D ^a   Ohmura, K ^a   Usui, T ^a   Fujii, T ^a   Ito, Y ^a   Iinuma, Y ^b   Mimori, T ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Interferon release assay; Mycobacterium tuberculosis infection; Systemic lupus erythematosus

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; INTERFERON-GAMMA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 80052726077     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203310397966     Document Type: Article

References (32)

1. Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 2003; 15: 528-534. (Pubitemid 37041388)
2. Zandman-Goddard G, Shoenfeld Y. SLE and infections. Clin Rev Allergy Immunol 2003; 25: 29-40.
3. Doria A, Canova M, Tonon M, et al. Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 2008; 8: 24-28.
4. Erdozain JG, Ruiz-Irastorza G, Egurbide MV, Martinez-Berriotxoa A, Aguirre C. High risk of tuberculosis in systemic lupus erythematosus? Lupus 2006; 15: 232-235.
5. Hou CL, Tsai YC, Chen LC, Huang JL. Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared. Clin Rheumatol 2008; 27: 557-563.
6. Mok MY, Lo Y, Chan TM, Wong WS, Lau CS. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. J Rheumatol 2005; 32: 609-615. (Pubitemid 40524690)
7. Chu AD, Polesky AH, Bhatia G, Bush TM. Active and latent tuberculosis in patients with systemic lupus erythematosus living in the United States. J Clin Rheumatol 2009; 15: 226-229.
8. Wallace DJ, Hahn BH. Dubois' lupus erythematosus, Seventh edn. Philadelphia, USA: Lippincott Williams & Wilkins; 2006. p. 964-965.
9. Prabu V, Agrawal S. Systemic lupus erythematosus and tuberculosis: A review of complex interactions of complicated diseases. J Postgrad Med 2010; 56: 244-250.
10. Huebner RE, Schein MF, Bass Jr JB. The tuberculin skin test. Clin Infect Dis 1993; 17: 968-975. (Pubitemid 23358739)
11. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-184.
12. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2006; 174: 736-742. (Pubitemid 44511654)
13. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277. (Pubitemid 13221242)
14. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
15. Matulis G, Juni P, Villiger PM, Gadola SD. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen- specific interferon gamma assay. Ann Rheum Dis 2008; 67: 84-90.
16. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54: 49-55.
17. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole-blood interferongamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006; 27: 442-448. (Pubitemid 43835524)
18. Bartalesi F, Vicidomini S, Goletti D, et al. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J 2009; 33: 586-593.
19. Pratt A, Nicholl K, Kay L. Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: the Newcastle (UK) experience. Rheumatology (Oxford) 2007; 46: 1035-1036. (Pubitemid 47062518)
20. Maeda T, Banno S, Maeda S, et al. Usefulness and limitations of QuantiFERON-TB Gold in Japanese rheumatoid arthritis patients: proposal to decrease the lower cutoff level for assessing latent tuberculosis infection. Mod Rheumatol 2010; 20: 18-23.
21. Kobashi Y, Sugiu T, Mouri K, Obase Y, Miyashita N, Oka M. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur Respir J 2009; 33: 812-815.
22. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev 2004; 3: 69-75. (Pubitemid 38293367)
23. Kumakura S, Ishikura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol 2004; 14: 205-215. (Pubitemid 39206664)
24. al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993; 13: 58-67. (Pubitemid 23047997)
25. Aringer M, Smolen JS. Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention. Lupus 2004; 13: 344-347. (Pubitemid 38788494)
26. Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979; 301: 5-8. (Pubitemid 9226519)
27. Robak E, Smolewski P, Wozniacka A, Sysa-Jedrzejowska A, Stepien H, Robak T. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus. Eur Cytokine Netw 2004; 15: 222-230. (Pubitemid 39389919)
28. La Cava A. Lupus, T cells. Lupus 2009; 18: 196-201.
29. Tozlu M, Kalyoncu U, Alp S, Unal S, Calguneri M. Diagnostic accuracy of Quantiferon TB test for patients with SLE and military tuberculosis. Rheumatol Int 2009; 29: 1395-1396.
30. Kimura M, Comstock GW, Mori T. Comparison of erythema and induration as results of tuberculin tests. Int J Tuberc Lung Dis 2005; 9: 853-857. (Pubitemid 41139642)
31. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000; 161: S221-S247.
32. Harada N, Higuchi K, Yoshiyama T, et al. Comparison of the sensitivity and specificity of two whole blood interferongamma assays for M. tuberculosis infection. J Infect 2008; 56: 348-353.